PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH RECOMBINANT INTERLEUKIN-2 von PALMER, PA, VINKE, J, PHILIP, T, NEGRIER, S, ATZOPODIEN, J, KIRCHNER, H, OSKAM, R, FRANKS, CR

Volltext

Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study von STOTER, G, AAMDAL, S, RODENHUIS, S, CLETON, F. J, IACOBELLI, S, FRANKS, C. R, OSKAM, R, SHILONI, E

Volltext

Home therapy with recombinant interleukin-2 and interferon-α2b in advanced human malignancies von Atzpodien, J., Korfer, A., Poliwoda, H., Kirchner, H., Franks, C.R.

Volltext

Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor von BLAY, J.-Y, FAVROT, M. C, NEGRIER, S, COMBARET, V, SALEM CHOUAIB, MERCATELLO, A, KAEMMERLEN, P, FRANKS, C. R, PHILIP, T

Volltext

Cardioxane—ICRF-187 towards anticancer drug specificity through selective toxicity reduction von Koning, J., Palmer, P., Franks, C.R., Mulder, D.E., Speyer, J.L., Green, M.D., Hellmann, K.

Volltext

A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian Cancer von Adams, M., Kerby, I. J., Rocker, I., Evans, A., Johansen, K., Franks, C. R.

Volltext

Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies von Atzpodien, J, Körfer, A, Franks, C R, Poliwoda, H, Kirchner, H

Volltext

Interleukin 2 therapy: current role in surgical oncological practice von Heys, S. D., Franks, C. R., Eremin, O.

Volltext

Interleukin 2 therapy in cancer: identification of responders von BROOM, J, HEYS, SD, WHITING, PH, PARK, KGM, STRACHAN, A, ROTHNIE, FRANKS, CR, EREMIN, O

Volltext

A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer von HAMBLIN, T. J, SADULLAH, S, WILLIAMSON, P, STEVENSON, J, OSKAM, R, PALMER, P, FRANKS, C. R

Volltext

INTERLEUKIN-2 AND INTERFERON-ALPHA IN THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER von JANSEN, RLH, SLINGERLAND, R, GOEY, SH, FRANKS, CR, BOLHUIS, RLH, STOTER, G

Volltext

Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma von NEGRIER, S, MERCATELLO, A, BRET, M, THIESSE, P, BLAY, JY, CORONEL, B, MERROUCHE, Y, OSKAM, R, FRANKS, CR, CLAVEL, M, MOSKOVTCHENKO, JF, PHILIP, T

Volltext

The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2 von Gore, M.E., Galligioni, E., Keen, C.W., Sorio, R., Loriaux, E.M., Grobben, H.C., Franks, C.R.

Volltext

A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma von Heys, S.D., Eremin, o., Ruggeri, E.M., Pein, F., Rainer, H., Oskam, R., de Peuter, R.A., Palmer, P.A., Franks, C.R.

Volltext

Interleukin-2 and lymphokine-activated killer cells in 15 children with advanced metastatic neuroblastoma von NEGRIER, S, MICHON, J, ANDREU, G, PALMER, P, FRANKS, C. R, ZUCKER, J. M, BERNARD, J. L, FRIDMAN, W. H, FAVROT, M, PHILIP, T, FLORET, D, BOUFFET, E, GENTET, J. C, PHILIP, I, COCHAT, P, STAMM, D, COSTIL, J, GASPARD, M

Volltext

The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2 von Scharenberg, J.G.M., Stam, A.G.M., von Blomberg, B.M.E., Roest, G.J., Palmer, P.A., Franks, C.R., Meijer, C.J.L.M., Scheper, R.J.

Volltext

PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-2 FOLLOWED BY RECOMBINANT TUMOR-NECROSIS-FACTOR IN PATIENTS WITH METASTATIC CANCER von NEGRIER, MS, POURREAU, CN, PALMER, PA, RANCHERE, JY, MERCATELLO, A, VIENS, P, BLAISE, D, JASMIN, C, MISSET, JL, FRANKS, CR, MARANINCHI, D, PHILIP, T

Volltext

A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma von Fiedler, W., Hossfeld, D.K., Jasmin, C., de Mulder, P.H.M., Pyrhönen, S., Palmer, P.A., Franks, C.R., Oskam, R.

Volltext

RECOMBINANT INTERLEUKIN-2 TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - EFFECT ON NATURAL CYTOTOXICITY von PARK, KGM, HEYS, SD, MURRAY, JB, HAYES, PD, ASHBY, JA, FRANKS, CR, EREMIN, O

Volltext

Local activation of immune response in bladder cancer patients treated with intraarterial infusion of recombinant interleukin-2 von VELOTTI, F, STOPPACIARO, A, POURREAU, C. N, PICCOLI, M, BARONI, C. D, FRATI, L, MIANO, L, SANTONI, A, RUCO, L, TUBARO, A, PETTINATO, A, MORRONE, S, NAPOLITANO, T, BOSSOLA, P. C, FRANKS, C. R, PALMER, P

Volltext